Chapters

Transcript

Video

From a safety perspective how do you counsel your patients in whom you are beginning PCSK9 inhibitor therapy?

From a safety perspective how do you counsel your patients in whom you are beginning PCSK9 inhibitor therapy?


Created by

CMEducation Resources IQ&A Interactive Intelligence Zone

Presenter

Matthew Roe, MD

Matthew Roe, MD

Professor of Medicine
Duke Clinical Research Institute
Duke University School of Medicine
Durham, NC